EAM
Eagle Asset Management’s Atara Biotherapeutics ATRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,687,143
| Closed | -$14.4M | – | 565 |
|
|
2020
Q1 | $14.4M | Buy |
1,687,143
+65,778
| +4% | +$560K | 0.09% | 232 |
|
|
2019
Q4 | $26.7M | Sell |
1,621,365
-13,775
| -0.8% | -$227K | 0.13% | 216 |
|
|
2019
Q3 | $23.1M | Buy |
1,635,140
+30,688
| +2% | +$433K | 0.12% | 219 |
|
|
2019
Q2 | $32.3M | Buy |
1,604,452
+62,690
| +4% | +$1.26M | 0.17% | 204 |
|
|
2019
Q1 | $61.3M | Sell |
1,541,762
-67,950
| -4% | -$2.7M | 0.33% | 125 |
|
|
2018
Q4 | $55.9M | Sell |
1,609,712
-15,246
| -0.9% | -$530K | 0.35% | 111 |
|
|
2018
Q3 | $67.2M | Buy |
1,624,958
+164,219
| +11% | +$6.79M | 0.32% | 115 |
|
|
2018
Q2 | $53.7M | Sell |
1,460,739
-25,828
| -2% | -$949K | 0.29% | 136 |
|
|
2018
Q1 | $58M | Sell |
1,486,567
-277
| -0% | -$10.8K | 0.32% | 112 |
|
|
2017
Q4 | $28.7M | Sell |
1,486,844
-3,232
| -0.2% | -$62.4K | 0.16% | 210 |
|
|
2017
Q3 | $25.8M | Sell |
1,490,076
-2,900
| -0.2% | -$50.2K | 0.15% | 230 |
|
|
2017
Q2 | $20.9M | Buy |
1,492,976
+225,367
| +18% | +$3.16M | 0.13% | 230 |
|
|
2017
Q1 | $26M | Buy |
1,267,609
+156,911
| +14% | +$3.22M | 0.16% | 187 |
|
|
2016
Q4 | $15.8M | Buy |
1,110,698
+130,025
| +13% | +$1.85M | 0.1% | 265 |
|
|
2016
Q3 | $21M | Buy |
980,673
+8,081
| +0.8% | +$173K | 0.14% | 211 |
|
|
2016
Q2 | $21.9M | Sell |
972,592
-53,396
| -5% | -$1.2M | 0.15% | 197 |
|
|
2016
Q1 | $19.5M | Buy |
1,025,988
+172,588
| +20% | +$3.28M | 0.14% | 219 |
|
|
2015
Q4 | $22.5M | Buy |
853,400
+290,968
| +52% | +$7.68M | 0.15% | 200 |
|
|
2015
Q3 | $17.7M | Buy |
+562,432
| New | +$17.7M | 0.12% | 229 |
|